Eduardo Núñez-rekin lankidetzan egindako argitalpenak (6)

2023

  1. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

    JACC: Heart Failure, Vol. 11, Núm. 11, pp. 1611-1622

2020

  1. Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study

    ESC Heart Failure, Vol. 7, Núm. 2, pp. 559-566

2017

  1. Early serum creatinine changes and outcomes in patients admitted for acute heart failure: the cardio-renal syndrome revisited

    European heart journal. Acute cardiovascular care, Vol. 6, Núm. 5, pp. 430-440

  2. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure

    European heart journal. Acute cardiovascular care, Vol. 6, Núm. 8, pp. 685-696

2016

  1. Serum neprilysin and recurrent hospitalizations after acute heart failure

    International Journal of Cardiology, Vol. 220, pp. 742-744

2014

  1. Red blood cell distribution width is longitudinally associated with mortality and anemia in heart failure patients

    Circulation Journal, Vol. 78, Núm. 2, pp. 410-418